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CORRESPONDENCE
How Many Claudicants Should be
Prescribed Statins?
Sir,
We read with interest the article by Harrison et al.1
which supports our previously published data indi-
cating that best medical therapy (BMT) is poorly
implemented in patients with peripheral arterial dis-
ease (PAD).2,3 However, we would have to take ser-
ious issue with the authors' apparent assertions that:
(1) there is no evidence of benefit from lowering total
cholesterol (TC) in PAD patients;
(2) only patients with a TC4 5 mmol/l require
treatment;
(3) a TC of 55 mmol/l remains the `` target'' level for
treatment.
The recently published, and very widely publicised,
U.K. Medical Research Council and British Heart
Foundation funded Heart Protection Study (HPS)
had proved beyond reasonable doubt that patients
with any symptomatic manifestation of atherosclerotic
vascular disease, including those with PAD, gain a
highly significant and clinically meaningful reduction
in cardiovascular morbidity and morbidity from a
25% reduction in TC levels through the prescription
of a statin (Simvastatin 40 mg).4 Importantly, this effect
was independent of age, gender, the presence or
absence of diabetes and baseline total cholesterol
down to 3.5 mmol/l. The implication of this landmark
trial is that virtually all patients with PAD should
receive an evidence-based dose of statin with a view
to reducing by approximately one-quarter their TC
regardless of their base-line TC.
S. D. Hobbs, T. Wilmink and A. W. Bradbury
Birmingham, U.K.
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The Abdominal Compartment Syndrome
Following Aortic Surgery
Sir,
We read with interest the review on abdominal com-
partment syndrome (ACS) by Loftus and Thompson.1
We would entirely agree that it is becoming increas-
ingly well recognised that this condition is not only
seen in polytrauma patients but also in elective and
emergency abdominal aortic surgery, and further-
more, may result from massive vigorous fluid
resuscitation.1,2
What may be less well known is that prolonged
operating time may also lead to ACS. This has been
described in two case reports (one following mesen-
teric revascularisation and one following bilateral
renal revascularisation) where only 1200±1500 ml of
fluid was found on abdominal decompression with-
out any evidence of gross bowel oedema but where
this was thought to have been sufficient to have
caused the syndrome.3,4 Obviously because of the
prolonged procedure, these patients would have had
massive fluid replacement which may have had some
part to play in the development of ACS but was not
thought to be the main factor. It should be remem-
bered that only a relatively small amount of intraper-
itoneal fluid is needed to cause this syndrome and that
other intra-abdominal vascular procedures may cause
it, in addition to abdominal aortic aneurysm repair.
A. Tiwari, F. Myint, J. L. Peters and G. Hamilton
London, U.K.
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